A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection

Clinical trial NCT01527110 · COMPLETED

Trial details

NCT number: NCT01527110
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2012-01-01
Primary completion: 2013-03-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.